The PTLA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PTLA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The PTLA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View PTLA Detailed Price Forecast - CNN Money||View PTLA Detailed Summary - Google Finance|
|View PTLA Detailed Summary - Yahoo! Finance||View PTLA Stock Research & Analysis - Zacks.com|
|View PTLA Trends & Analysis - Trade-Ideas||View PTLA Major Holders - Barrons|
|View PTLA Call Transcripts - NASDAQ||View PTLA Breaking News & Analysis - Seeking Alpha|
|View PTLA Annual Report - CompanySpotlight.com||View PTLA OTC Short Report - OTCShortReport.com|
|View PTLA Fundamentals - TradeKing||View PTLA SEC Filings - Bar Chart|
|View Historical Prices for PTLA - The WSJ||View Performance/Total Return for PTLA - Morningstar|
|View the Analyst Estimates for PTLA - MarketWatch||View the Earnings History for PTLA - CNBC|
|View the PTLA Earnings - StockMarketWatch||View PTLA Buy or Sell Recommendations - MacroAxis|
|View the PTLA Bullish Patterns - American Bulls||View PTLA Short Pain Metrics - ShortPainBot.com|
|View PTLA Stock Mentions - StockTwits||View PTLA Stock Mentions - PennyStockTweets|
|View PTLA Stock Mentions - Twitter||View PTLA Investment Forum News - Investor Hub|
|View PTLA Stock Mentions - Yahoo! Message Board||View PTLA Stock Mentions - Seeking Alpha|
|View Insider Transactions for PTLA - SECform4.com||View Insider Transactions for PTLA - Insider Cow|
|View PTLA Major Holdings Summary - CNBC||View Insider Disclosure for PTLA - OTC Markets|
|View Insider Transactions for PTLA - Yahoo! Finance||View Institutional Holdings for PTLA - NASDAQ|
|View PTLA Stock Insight & Charts - FinViz.com||View PTLA Investment Charts - StockCharts.com|
|View PTLA Stock Overview & Charts - BarChart||View PTLA User Generated Charts - Trading View|
Why Portola Pharmaceuticals Stock Shed 11% in September
Posted on Thursday October 11, 2018
The biotech specialist is transitioning to a new management team under difficult operating conditions.
What You Must Know About Portola Pharmaceuticals Inc’s (NASDAQ:PTLA) Market Risks
Posted on Tuesday October 09, 2018
If you own shares in Portola Pharmaceuticals Inc (NASDAQ:PTLA) then it’s worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure
Portola Pharmaceuticals Supports 2018 World Thrombosis Day Campaign to Raise Awareness of Blood Clots as an Urgent and Growing Health Crisis
Posted on Tuesday October 09, 2018
Portola Pharmaceuticals, Inc.® (PTLA) today announced its 2018 partnership with the World Thrombosis Day campaign to help raise global awareness of thrombosis. Observed annually on October 13, World Thrombosis Day is led by the International Society on Thrombosis and Haemostasis (ISTH), which has mobilized more than 1,500 partner organizations worldwide this year to shine a spotlight on the burden of arterial or venous thrombosis – the potentially life-threatening formation of blood clots in an artery or vein – and conditions caused by it.
Recent Developments for Portola Pharmaceuticals
Posted on Monday October 08, 2018
In September 2018, the US FDA granted Portola Pharmaceuticals’ cerdulatinib, an investigational Syk/JAK inhibitor, an orphan drug designation for peripheral T-cell lymphoma (or PTCL) therapy. The FDA grants this designation to support the development of therapies for rare diseases. This designation provides benefits such as seven years of market exclusivity after approval, tax credits for certain clinical trials, and exemption of FDA application fees.